Year: 2023
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Identification of rare variants involved in complex, polygenic diseases like Crohn's disease (CD) has accelerated with the introduction of whole exome/genome sequencing association studies. Rare variants can be used in both diagnostic and therapeutic assessments; however, since they are likely to be restricted to specific ancestry groups, their contributions to risk assessment need to be evaluated outside the discovery population. Prior studies implied that the three known rare variants in NOD2 are absent in West African and Asian populations and only contribute in African Americans via admixture. METHODS: Whole genome sequencing (WGS) data from 3418 African American individuals, 1774 inflammatory bowel disease (IBD) cases, and 1644 controls were used to assess odds ratios and allele frequencies (AF), as well as haplotype-specific ancestral origins of European-derived CD variants discovered in a large exome-wide association study. Local and global ancestry was performed to assess the contribution of admixture to IBD contrasting European and African American cohorts. RESULTS: Twenty-five rare variants associated with CD in European discovery cohorts are typically five-fold lower frequency in African Americans. Correspondingly, where comparisons could be made, the rare variants were found to have a predicted four-fold reduced burden for IBD in African Americans, when compared to European individuals. Almost all of the rare CD European variants were found on European haplotypes in the African American cohort, implying that they contribute to disease risk in African Americans primarily due to recent admixture. In addition, proportion of European ancestry correlates the number of rare CD European variants each African American individual carry, as well as their polygenic risk of disease. Similar findings were observed for 23 mutations affecting 10 other common complex diseases for which the rare variants were discovered in European cohorts. CONCLUSIONS: European-derived Crohn's disease rare variants are even more rare in African Americans and contribute to disease risk mainly due to admixture, which needs to be accounted for when performing cross-ancestry genetic assessments.
Source: Genome Medicine
Institutions: Georgia Institute of Technology, Emory University, Montreal Heart Institute, Université de Montréal, Icahn School of Medicine at Mount Sinai, Rutgers, The State University of New Jersey, Johns Hopkins University, Johns Hopkins Medicine, Cedars-Sinai Medical Center, Children's Healthcare of Atlanta
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,690
Awards: Genomic Analysis of Perianal Fistulizing Crohn's Disease across Ancestries, New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel disease, Gene discoveries in subjects with Crohn's disease of African descent, Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBD, Mount Sinai NYC Genetics Research Center: Multi-omic integration across data-types, cell niches and populations, Transcriptomics of Pain in Sickle Cell Disease, IBD Gene Mapping by Clinical and Population Subset, Genomic and Immunologic Characterization of Inflammatory Bowel Disease and its Phenotypes
OpenAlex ID: W4388704591
